🦊/People

Hans J. Moebius

InvestorFounder

Venture Advisor at Andera Partners · Co-founder and CMO, Head of Clinical Operations at Exciva Website

Baar, Zug, Switzerland

FoundedExciva Website

Find your path to Hans

276 people in our graph share verified history with Hans — schools, employers, funds. One of them is your warm intro.

Johannes FruehaufunlockedHans: together at Goethe University Frankfurt (1989–1991)
×6Hans: together at Heidelberg University
×4Hans: together at Goethe University Frankfurt
Hans: together at Anderapartners

About

Hans J. Moebius is a Venture Advisor at Andera Partners, focusing on central nervous system drug development. He holds a B.S. in Chemistry, a medical degree, and a PhD in Experimental Pharmacology, and is a board-certified neurologist (FAAN) and psychiatrist with a European Certificate in Pharmaceutical Medicine. His career spans over a decade of clinical work in university settings and more than 30 years in the pharmaceutical industry, including a role as Chief Medical Officer during Athira's 2020 IPO and involvement in the development of therapies for conditions such as Alzheimer's disease, hepatic encephalopathy, Lennox-Gastaut syndrome, and ADHD.

Co-founder and CMO, Head of Clinical Operations at Exciva Website

Intro paths

In turn, Hans can intro founders to Exciva Website's investors below.

Co-founders at Exciva Website

ABAnton Bespalov
Anton BespalovCo-founder and CSO, Head of Regulatory Affairs

Experience

  1. Andera PartnersVenture Advisorcurrent2024 — present
  2. EXCIVA GmbHCo-Founder and Chief Medical Officercurrent2024 — presentHeidelberg, Baden-Württemberg, Germany
  3. EXCIVA GmbHScientific Advisory Board member2019 — 2024Heidelberg, Baden-Württemberg, Germany
  4. EXCIVA GmbHCo-Founder, CEO and CMO2016 — 2019Heidelberg, Baden-Württemberg, Germany
  5. Athira PharmaSenior Scientific Advisorcurrent2024 — presentBothell, Washington, United States
  6. Athira PharmaCMO2019 — 2024Bothell, Washington, United States
  7. Rodin TherapeuticsChief Medical Officer2016 — 2017Cambridge, Massachusetts, United States
  8. FORUM Pharmaceuticals Inc.VP Clinical Research Europe2012 — 2016Zürich Area, Switzerland
  9. CHASE PharmaceuticalsExec. VP R&D2016Washington DC
  10. TauRx Therapeutics Ltd.Chief Medical Officer2009 — 2012Singapore
  11. INC ResearchSenior Vice President2007 — 2009Raleigh, NC and Zurich, Switzerland
  12. Merz PharmaceuticalsCSO1996 — 2006Frankfurt/M, Germany
  13. NovartisHead Global Medical Affairs, CNS1995 — 1996Basel
  14. CibaClinical R&D CNS1991 — 1995Basel, Switzerland

Skills & more

Clinical Development35Neurology27Pharmaceutical Industry24Clinical Research20Medical Affairs9Psychiatry8CRO7Clinical Trials16Regulatory Affairs4Pharmacology3Neuroscience4Drug Development16
+7 moreTranslational MedicineAlzheimer's diseaseR&DLifesciencesBiotechnologyMedicineLife Sciences

Languages English · French · German · Italian

From Hans's professional profile.

Colleagues at Andera Partners

Frequently asked questions

Who is Hans J. Moebius?
Hans J. Moebius is a Venture Advisor at Andera Partners, focusing on central nervous system drug development. He holds a B.S. in Chemistry, a medical degree, and a PhD in Experimental Pharmacology, and is a board-certified neurologist (FAAN) and psychiatrist with a European Certificate in Pharmaceutical Medicine. His career spans over a decade of clinical work in university settings and more than 30 years in the pharmaceutical industry, including a role as Chief Medical Officer during Athira's 2020 IPO and involvement in the development of therapies for conditions such as Alzheimer's disease, hepatic encephalopathy, Lennox-Gastaut syndrome, and ADHD.
Where does Hans J. Moebius work?
Hans J. Moebius is Co-founder and CMO, Head of Clinical Operations of Exciva Website and Venture Advisor at Andera Partners.
What companies did Hans J. Moebius found?
Hans J. Moebius founded Exciva Website.
Where did Hans J. Moebius go to school?
Hans J. Moebius studied at Goethe University Frankfurt (Board Certifications Neurology, Psychiatry); Max-Planck-Institute for Brain Research, Frankfurt/M (Neurodegenerative diseases, neuro-oncology); Heidelberg University (MD, PhD).

Same school

Shared employers